BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36758857)

  • 1. 2-Aminoethoxydiphenyl borate ameliorates mitochondrial dysfunctions in MPTP/MPP
    Vaidya B; Polepalli M; Sharma SS; Singh JN
    Mitochondrion; 2023 Mar; 69():95-103. PubMed ID: 36758857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective Potential of HC070, a Potent TRPC5 Channel Inhibitor in Parkinson's Disease Models: A Behavioral and Mechanistic Study.
    Vaidya B; Roy I; Sharma SS
    ACS Chem Neurosci; 2022 Sep; 13(18):2728-2742. PubMed ID: 36094343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teaghrelin protected dopaminergic neurons in MPTP-induced Parkinson's disease animal model by promoting PINK1/Parkin-mediated mitophagy and AMPK/SIRT1/PGC1-α-mediated mitochondrial biogenesis.
    Jhuo CF; Chen CJ; Tzen JTC; Chen WY
    Environ Toxicol; 2024 Jul; 39(7):4022-4034. PubMed ID: 38622810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of Parkinson's disease by pharmacological inhibition and knockdown of redox sensitive TRPC5 channels: Focus on mitochondrial health.
    Vaidya B; Gupta P; Laha JK; Roy I; Sharma SS
    Life Sci; 2023 Sep; 328():121871. PubMed ID: 37352915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
    Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
    Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of TFAM, NRF-1 and myr-AKT protects the MPP(+)-induced mitochondrial dysfunctions in neuronal cells.
    Piao Y; Kim HG; Oh MS; Pak YK
    Biochim Biophys Acta; 2012 May; 1820(5):577-85. PubMed ID: 21856379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of Suhexiang Wan on the in vitro and in vivo models of Parkinson's disease.
    Liu Q; Sang Heon K; Yung-Wei S; Sok Cheon P; Wonwoong L; Jongki H; Jaehwan J; Kyoung Sang C; Songhee J; Byung-Soo K
    J Tradit Chin Med; 2019 Dec; 39(6):800-808. PubMed ID: 32186150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel tetramethylpyrazine bis-nitrone (TN-2) protects against MPTP/MPP+-induced neurotoxicity via inhibition of mitochondrial-dependent apoptosis.
    Xu D; Duan H; Zhang Z; Cui W; Wang L; Sun Y; Lang M; Hoi PM; Han Y; Wang Y; Lee SM
    J Neuroimmune Pharmacol; 2014 Mar; 9(2):245-58. PubMed ID: 24233519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Potential Neuroprotective Effects of Vanillin Against MPP
    Rani L; Ghosh B; Ahmad MH; Mondal AC
    Mol Neurobiol; 2023 Aug; 60(8):4693-4715. PubMed ID: 37145378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
    Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y
    Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperbaric Oxygen Therapy Improves Parkinson's Disease by Promoting Mitochondrial Biogenesis via the SIRT-1/PGC-1α Pathway.
    Hsu HT; Yang YL; Chang WH; Fang WY; Huang SH; Chou SH; Lo YC
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro.
    Lee DH; Kim CS; Lee YJ
    Food Chem Toxicol; 2011 Jan; 49(1):271-80. PubMed ID: 21056612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson's disease and in MPP+ -treated MN9D cells in vitro.
    Sivasubramanian M; Kanagaraj N; Dheen ST; Tay SS
    Neuroscience; 2015 Apr; 290():636-48. PubMed ID: 25637806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ndfip1 protected dopaminergic neurons via regulating mitochondrial function and ferroptosis in Parkinson's disease.
    Fu X; Qu L; Xu H; Xie J
    Exp Neurol; 2024 May; 375():114724. PubMed ID: 38365133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple herbal extract DA-9805 exerts a neuroprotective effect via amelioration of mitochondrial damage in experimental models of Parkinson's disease.
    Jeong JS; Piao Y; Kang S; Son M; Kang YC; Du XF; Ryu J; Cho YW; Jiang HH; Oh MS; Hong SP; Oh YJ; Pak YK
    Sci Rep; 2018 Oct; 8(1):15953. PubMed ID: 30374025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIPK1 inhibitor ameliorates the MPP
    Liu J; Hu H; Wu B
    Brain Res; 2021 Apr; 1757():147310. PubMed ID: 33524379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPM2 Promotes Neurotoxin MPP
    Sun Y; Sukumaran P; Selvaraj S; Cilz NI; Schaar A; Lei S; Singh BB
    Mol Neurobiol; 2018 Jan; 55(1):409-420. PubMed ID: 27957685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis.
    Ren ZL; Wang CD; Wang T; Ding H; Zhou M; Yang N; Liu YY; Chan P
    Acta Pharmacol Sin; 2019 Apr; 40(4):441-450. PubMed ID: 29991712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of PGC-1α Influences Mitochondrial Signal Transduction of Dopaminergic Neurons.
    Ye Q; Huang W; Li D; Si E; Wang J; Wang Y; Chen C; Chen X
    Mol Neurobiol; 2016 Aug; 53(6):3756-3770. PubMed ID: 26141122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Study of Overexpression of Peroxiredoxin-2 Reduces MPP
    Liu M; Zuo S; Guo X; Peng J; Xing Y; Guo Y; Li C; Xing H
    Neurochem Res; 2023 Jul; 48(7):2129-2137. PubMed ID: 36808393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.